Quantum BioPharma Ltd. Adjustments For Increase Decrease In Trade And Other Payables
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Increase Decrease In Trade And Other Payables of $4.27 million for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-03-31.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2025-03-31
CAD
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|
| 2019-12-31 | 825.12K CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 433.75K CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 3 month | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 9 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.13M derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | $4.29M derived: sum of 2 quarters · filed 2025-03-31 | $4.27M 20-F/A · filed 2025-03-31 | |
| 2024-09-30 | $1.16M derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $1.15M 6-K · filed 2024-11-12 | ||
| 2024-06-30 | -$17.70K 6-K/A · filed 2024-08-19 | |||
| 2023-12-31 | $575.08K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-03-31 | $1.13M derived: sum of 2 quarters · filed 2025-03-31 | $2.05M 20-F/A · filed 2025-03-31 | |
| 2023-09-30 | $554.76K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $1.47M 6-K · filed 2024-11-12 | ||
| 2023-06-30 | $919.95K 6-K/A · filed 2024-08-19 | |||
| 2022-12-31 | -$699.78K 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | $3.60M 20-F · filed 2024-04-02 | |||
| 2020-12-31 | $898.69K 20-F · filed 2023-03-31 | |||
| 2019-12-31 | $1.52M 40-F · filed 2021-03-17 |